chr18-26052643-C-T
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_001007559.3(SS18):c.588G>A(p.Met196Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000353 in 1,614,018 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001007559.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SS18 | NM_001007559.3 | c.588G>A | p.Met196Ile | missense_variant | 5/11 | ENST00000415083.7 | NP_001007560.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SS18 | ENST00000415083.7 | c.588G>A | p.Met196Ile | missense_variant | 5/11 | 1 | NM_001007559.3 | ENSP00000414516 | A1 |
Frequencies
GnomAD3 genomes AF: 0.000204 AC: 31AN: 152184Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000597 AC: 15AN: 251408Hom.: 0 AF XY: 0.0000810 AC XY: 11AN XY: 135880
GnomAD4 exome AF: 0.0000178 AC: 26AN: 1461716Hom.: 0 Cov.: 31 AF XY: 0.0000193 AC XY: 14AN XY: 727164
GnomAD4 genome AF: 0.000204 AC: 31AN: 152302Hom.: 0 Cov.: 33 AF XY: 0.000201 AC XY: 15AN XY: 74482
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 06, 2023 | The c.588G>A (p.M196I) alteration is located in exon 5 (coding exon 5) of the SS18 gene. This alteration results from a G to A substitution at nucleotide position 588, causing the methionine (M) at amino acid position 196 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at